Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about DAM microglia: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Cell Type | DAM microglia |
| Also Known As | DAM, Activated microglia, AD-associated microglia, ARM (activated response microglia) |
| Key Pathways | TREM2/DAP12 signaling, PI3K/AKT/mTOR (downstream of TREM2), Phagocytosis (Abeta/tau), Lipid metabolism upregulation, Complement activation |
| Associated Diseases | Alzheimer's disease (primary), Frontotemporal dementia, ALS, Multiple sclerosis, Parkinson's disease |
| Related Genes | ADAM10, ALS, APOE, APOE4, ATP, C3 |
| Linked Hypotheses | 316 hypotheses |
graph TD
DAM_microglia["DAM microglia"] -->|"active in"| senescence["senescence"]
style senescence fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
DAM_microglia["DAM microglia"] -->|"active in"| oxidative_stress_response["oxidative stress response"]
style oxidative_stress_response fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
DAM_microglia["DAM microglia"] -->|"active in"| unfolded_protein_response["unfolded protein response"]
style unfolded_protein_response fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
DAM_microglia["DAM microglia"] -->|"active in"| mitochondrial_function["mitochondrial function"]
style mitochondrial_function fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
DAM_microglia["DAM microglia"] -->|"active in"| autophagy_pathway["autophagy pathway"]
style autophagy_pathway fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
DAM_microglia["DAM microglia"] -->|"active in"| complement_cascade["complement cascade"]
style complement_cascade fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
DAM_microglia["DAM microglia"] -->|"active in"| NAD__metabolism["NAD+ metabolism"]
style NAD__metabolism fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#fff
TREM2["TREM2"] -->|"expressed in"| DAM_microglia["DAM microglia"]
style TREM2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
DNA["DNA"] -->|"expressed in"| DAM_microglia["DAM microglia"]
style DNA fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
PINK1["PINK1"] -->|"expressed in"| DAM_microglia["DAM microglia"]
style PINK1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
C3["C3"] -->|"expressed in"| DAM_microglia["DAM microglia"]
style C3 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
APOE4["APOE4"] -->|"expressed in"| DAM_microglia["DAM microglia"]
style APOE4 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#fff
style DAM_microglia fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold| Target | Relation | Type | Str |
|---|---|---|---|
| ubiquitin-proteasome | expressed_in | pathway | 0.85 |
| senescence | active_in | pathway | 0.85 |
| oxidative stress response | active_in | pathway | 0.85 |
| unfolded protein response | active_in | pathway | 0.85 |
| mitochondrial function | active_in | pathway | 0.85 |
| autophagy pathway | active_in | pathway | 0.85 |
| complement cascade | active_in | pathway | 0.85 |
| epigenetic regulation | active_in | pathway | 0.85 |
| NAD+ metabolism | active_in | pathway | 0.85 |
| sphingolipid metabolism | active_in | pathway | 0.75 |
| pyroptosis | active_in | pathway | 0.75 |
| purinergic signaling | active_in | pathway | 0.75 |
| insulin signaling | active_in | pathway | 0.75 |
| lipid metabolism | active_in | pathway | 0.75 |
| circadian regulation | active_in | pathway | 0.65 |
| NF-kB signaling | active_in | pathway | 0.65 |
| neurotrophin signaling | active_in | pathway | 0.55 |
| blood-brain barrier | active_in | pathway | 0.55 |
| ferroptosis | active_in | pathway | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| 37165437 | exhibit | paper | 0.90 |
| TREM2 | activates | protein | 0.90 |
| APOE | expressed_in | gene | 0.85 |
| APOE4 | expressed_in | gene | 0.85 |
| TNF | expressed_in | gene | 0.85 |
| C3 | expressed_in | gene | 0.85 |
| GFAP | expressed_in | gene | 0.85 |
| NAD | expressed_in | gene | 0.85 |
| PINK1 | expressed_in | gene | 0.85 |
| TDP-43 | expressed_in | gene | 0.85 |
| TREM2 | expressed_in | gene | 0.85 |
| DNA | expressed_in | gene | 0.85 |
| RNA | expressed_in | gene | 0.85 |
| ROS | expressed_in | gene | 0.75 |
| ALS | expressed_in | gene | 0.75 |
| APOE3 | expressed_in | gene | 0.75 |
| P2RY12 | expressed_in | gene | 0.75 |
| ADAM10 | expressed_in | gene | 0.75 |
| IL-6 | expressed_in | gene | 0.75 |
| NLRP3 | expressed_in | gene | 0.75 |
| ATP | expressed_in | gene | 0.75 |
| AQP4 | expressed_in | gene | 0.75 |
| YKL-40 | expressed_in | gene | 0.65 |
| P2X7 | expressed_in | gene | 0.65 |
| TFEB | expressed_in | gene | 0.65 |
| C1QA | expressed_in | gene | 0.65 |
| SQSTM1 | expressed_in | gene | 0.65 |
| LAMP1 | expressed_in | gene | 0.65 |
| CX3CR1 | expressed_in | gene | 0.65 |
| SOD1 | expressed_in | gene | 0.65 |
| ADAM17 | expressed_in | gene | 0.65 |
| AMPK | expressed_in | gene | 0.65 |
| TMEM119 | expressed_in | gene | 0.65 |
| H2AX | expressed_in | gene | 0.65 |
| APP | expressed_in | gene | 0.65 |
| S100B | expressed_in | gene | 0.65 |
| PTEN | expressed_in | gene | 0.65 |
| CD68 | expressed_in | gene | 0.65 |
| PARP1 | expressed_in | gene | 0.65 |
| EPHB4 | expressed_in | gene | 0.55 |
| BCL-2 | expressed_in | gene | 0.55 |
| DRP1 | expressed_in | gene | 0.55 |
| KDM6A | expressed_in | gene | 0.55 |
| FOXO3 | expressed_in | gene | 0.55 |
| AHR | expressed_in | gene | 0.55 |
| TLR4 | expressed_in | gene | 0.55 |
| BDNF | expressed_in | gene | 0.55 |
| CLDN5 | expressed_in | gene | 0.55 |
| OCLN | expressed_in | gene | 0.55 |
| TAR | expressed_in | gene | 0.55 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Cell-Type Specific TREM2 Upregulation in DAM Microglia | 0.761 | Alzheimer's Disease | SEA-AD Gene Expression Profiling — Allen |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Anti-ASC antibody intracerebroventricular injection in APP/PS1 mice | validation | Alzheimer's disease | 0.950 | 0.00 | APP/PS1 transgenic mice (8 mon | proposed | N/A |
| Curcumin-Licorice Combination in D-galactose/Sodium Nitrite AD Model | validation | Alzheimer's disease | 0.950 | 0.00 | C57BL/6 mice | proposed | N/A |
| SPP1 upregulation in perivascular cells in AD mouse models | exploratory | Alzheimer's disease | 0.900 | 0.00 | AD mouse models | proposed | N/A |
| Tet2 modulation in Aβ42-injured mouse hippocampal neurons | exploratory | Alzheimer's disease | 0.900 | 0.00 | primary mouse hippocampal neur | proposed | N/A |
| AAV-mediated Tet2 modulation in 2×Tg-AD mice behavioral study | validation | Alzheimer's disease | 0.900 | 0.00 | young APPswe/PSEN1 double-tran | proposed | N/A |
| Cerebrovascular function analysis in CD2AP mutant mice | validation | Alzheimer's disease | 0.900 | 0.00 | mice | proposed | N/A |
| Cerebral blood flow regulation in CD2AP mutant mice | validation | Alzheimer's disease | 0.880 | 0.00 | mice | proposed | N/A |
| Abeta-induced cell death and aggregation in GD3S-deficient neurons | exploratory | Alzheimer's disease | 0.850 | 0.00 | primary neurons and astrocytes | proposed | N/A |
| Generation of Aβ-specific Tregs using CRISPR-Cas9 | exploratory | Alzheimer's disease | 0.850 | 0.00 | engineered Tregs | proposed | N/A |
| Cell-cell interaction analysis of perivascular-microglial crosstalk | exploratory | Alzheimer's disease | 0.800 | 0.00 | AD mouse models | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Transcriptomic cytoarchitecture reveals principles of human neocortex organizati [PMID:37824655] | Jorstad NL, Close J, Johansen N, Yanny A | Science | 2023 | 186 |
| Integrated multimodal cell atlas of Alzheimer’s disease [PMID:37292694] | Gabitto MI, Travaglini KJ, Rachleff VM, | Research Square | 2023 | 63 |
| Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2- [PMID:31932797] | Zhou Y, Song WM, Andhey PS, Swain A, Lev | Nat Med | 2020 | 1 |
| Moderate Effects of the Arginine to Histidine R47H Variant of the Triggering Rec [PMID:41890852] | ["Ramirez G", "Hernandez D", "Teal A", " | Research square | 2026 | 0 |
| Increased plasma soluble TREM2 levels in non-Alzheimer's dementia. [PMID:41920402] | Güven Gamze; Gezegen Haşim; & | Acta neurologica Belgica | 2026 | 0 |
| AI-guided design of cyclic peptide binders targeting TREM2 using CycleRFdiffusio [PMID:41435973] | Cho S, Zhu R, Kuncewicz K, Duan H, Gabr | Bioorg Med Chem Lett | 2026 | 0 |
| ITAM-Syk signaling mediates the rebound phenomenon after anti-RANKL antibody dis [PMID:41490759] | Ishizu H, Hasegawa T, Shimizu T, Yamamot | Bone | 2026 | 0 |
| Oxaliplatin-artesunate conjugate intensifies suppression on colorectal cancer by [PMID:41520444] | Tan Y, Yang T, Jiang S, Li S, Cai L et a | J Inorg Biochem | 2026 | 0 |
| Loss of Triggering Receptor Expressed on Myeloid Cells 2 Impairs Microglial Func [PMID:41643896] | Chen G, Wang Z, Zhao C, Wang C, Li Y et | Am J Pathol | 2026 | 0 |
| Microglial metabolic reprogramming in Alzheimer's disease: Pathways, mechanisms, [PMID:41651180] | Yang FG, Yang H, Han SW, Wang JT, Gao W | Ageing Res Rev | 2026 | 0 |
| Plant-derived bioactive compounds modulate the gut microbiota in Alzheimer's dis [PMID:41678917] | Xue D, Hu X, Li R, Sun T, Qian S et al. | Phytomedicine | 2026 | 0 |
| Triggering Receptor Expressed on Myeloid Cells-2 Regulates Innate Lymphoid Cell [PMID:41928407] | Shen HC, Chen NJ, Sun CY, Yu WK, Su VY e | Kaohsiung J Med Sci | 2026 | 0 |
| TREM2 deficiency delays postnatal microglial maturation and synaptic pruning, le [PMID:41930604] | Yang HC, Deng YS, Zhang J, Zhang T, Song | J Alzheimers Dis | 2026 | 0 |
| Population-scale burden analysis of rare damaging coding variants identifies nov [PMID:41867223] | Le Guen Y, Peña-Tauber A, Pulgrossi RC, | medRxiv : the preprint server | 2026 | 0 |
| TREM2 as a possible link between Alzheimer's disease and diabetes mellitus. [PMID:41862118] | Chen W, Huang N, Huang W, Wang M, Luo Y, | Experimental neurology | 2026 | 0 |
| The microglial TREM2 receptor programs hippocampal development in a mouse model [PMID:41887542] | Ahmed S, Bowers C, Munoz-Martin J, Jamwa | Brain, behavior, and immunity | 2026 | 0 |
| Neuroinflammation and Alzheimer's disease: Unravelling the molecular mechanisms. [PMID:40938771] | Kakkar A, Singh H, Singh BK, Kumar A, Mi | Journal of Alzheimer's disease | 2025 | 0 |
| Dehydroervatamine as a promising novel TREM2 agonist, attenuates neuroinflammati [PMID:39609160] | Li L, Xu N, He Y, Tang M, Yang B, Du J, | Neurotherapeutics : the journa | 2025 | 0 |
| TREM2 regulates microglial lipid droplet formation and represses post-ischemic b [PMID:38042110] | Wei W, Zhang L, Xin W, Pan Y, Tatenhorst | Biomedicine & pharmacotherapy | 2024 | 0 |
| Defects in lysosomal function and lipid metabolism in human microglia harboring [PMID:37115208] | Filipello F, You SF, Mirfakhar FS, Mahal | Acta neuropathologica | 2023 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning DAM microglia in their description or question text
No additional research found